← Leaderboards
Stan Gee Louie
University Of Southern California
$1,807,374
Attributed
$4,355,335
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,355,335 · 4
By mechanism
R01$1,909,202 · 1
U01$1,480,275 · 1
P30$635,952 · 1
R41$329,906 · 1
Top collaborators
- Steven David Mittelman5 shared
- Michael Neely5 shared
- Nicos A Petasis2 shared
- Kai Chen1 shared
- Vsevolod Katritch1 shared
- Hussein N Yassine1 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Hussein N Yassine$19,354,869
- Bo Han$926,777
- David Gelmont$191,317
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsLeadIn VitroDrug KineticsBaseChildhoodSamplingPharmacodynamicsAffectTherapy ResistantChemotherapyModalityMalignant NeoplasmsMediatingEnvironmentEvaluationResistanceDesignCancer CellDiagnosisAlzheimer&AposClinical ResearchMetabolismIn Vivo
Grant awards (13)
Drug Development for Alzheimer's neuroinflammation$1,480,275
U01 · FY2025 · AG
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment$410,198
R01 · FY2021 · CA
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment$380,446
R01 · FY2020 · CA
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment$375,060
R01 · FY2019 · CA
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment$363,465
R01 · FY2018 · CA
Development of a new small molecule therapeutic for the treatment of resistant breast cancer$50,000
R41 · FY2018 · CA · contact PI
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment$380,033
R01 · FY2017 · CA
Development of a new small molecule therapeutic for the treatment of resistant breast cancer$279,906
R41 · FY2017 · CA · contact PI
Pharmacoanalytic Core Laboratory$147,914
P30 · FY2010 · CA · contact PI
Pharmacoanalytic Core Laboratory$150,004
P30 · FY2009 · CA · contact PI
Pharmacoanalytic Core Laboratory$128,454
P30 · FY2008 · CA · contact PI
Pharmacoanalytic Core Laboratory$144,435
P30 · FY2007 · CA · contact PI
Pharmacoanalytic Core Laboratory$65,145
P30 · FY2006 · CA · contact PI